{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:01:20Z","timestamp":1794330080563,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFC2501204"],"award-info":[{"award-number":["2021YFC2501204"]}]},{"name":"Major Program of the National Natural Science Foundation of China","award":["22494704"],"award-info":[{"award-number":["22494704"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873785"],"award-info":[{"award-number":["81873785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Technology Major Project of Hunan Provincial Science and Technology Department","award":["2021SK1011"],"award-info":[{"award-number":["2021SK1011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12035-025-05257-x","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T15:12:54Z","timestamp":1753715574000},"page":"15916-15927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Deficiency of PLA2G6 Induces Ferroptosis in Dopaminergic Neurons and Contributes to Parkinson\u2019s Disease Pathogenesis via Disruption of PRDX6\/FTH1\/GPX4 Axis"],"prefix":"10.1007","volume":"62","author":[{"given":"Taole","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiurong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-3928","authenticated-orcid":false,"given":"Jifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"4","key":"5257_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jamaneurol.2020.5257","volume":"78","author":"DA Kia","year":"2021","unstructured":"Kia DA, Zhang D, Guelfi S et al (2021) Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets. JAMA Neurol 78(4):464\u2013472","journal-title":"JAMA Neurol"},{"key":"5257_CR2","doi-asserted-by":"crossref","unstructured":"Ma Z, Wang X, Nowatzke W, Ramanadham S, Turk J (1999) Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1. J Biol Chem 274(14):9607\u20139616","DOI":"10.1074\/jbc.274.14.9607"},{"key":"5257_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101957","volume":"89","author":"X Deng","year":"2023","unstructured":"Deng X, Yuan L, Jankovic J, Deng H (2023) The role of the PLA2G6 gene in neurodegenerative diseases. Ageing Res Rev 89:101957","journal-title":"Ageing Res Rev"},{"issue":"10","key":"5257_CR4","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1021\/cr200085w","volume":"111","author":"EA Dennis","year":"2011","unstructured":"Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G (2011) Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 111(10):6130\u20136185","journal-title":"Chem Rev"},{"key":"5257_CR5","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/brain\/awv132","volume":"138","author":"KJ Kinghorn","year":"2015","unstructured":"Kinghorn KJ, Castillo-Quan JI, Bartolome F et al (2015) Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction. Brain 138:1801\u20131816","journal-title":"Brain"},{"issue":"7","key":"5257_CR6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ng1826","volume":"38","author":"NV Morgan","year":"2006","unstructured":"Morgan NV, Westaway SK, Morton JE et al (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38(7):752\u2013754","journal-title":"Nat Genet"},{"issue":"1","key":"5257_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/mds.28807","volume":"37","author":"F Magrinelli","year":"2022","unstructured":"Magrinelli F, Mehta S, Di Lazzaro G et al (2022) Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism. Mov Disord 37(1):148\u2013161","journal-title":"Mov Disord"},{"key":"5257_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107114","volume":"202","author":"J Liu","year":"2024","unstructured":"Liu J, Tan J, Tang B, Guo J (2024) Unveiling the role of iPLA2\u03b2 in neurodegeneration: From molecular mechanisms to advanced therapies. Pharmacol Res 202:107114","journal-title":"Pharmacol Res"},{"issue":"5","key":"5257_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"issue":"12","key":"5257_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B et al (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16(12):1180\u20131191","journal-title":"Nat Cell Biol"},{"issue":"1\u20132","key":"5257_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331","journal-title":"Cell"},{"key":"5257_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.freeradbiomed.2020.03.015","volume":"152","author":"P Zhang","year":"2020","unstructured":"Zhang P, Chen L, Zhao Q et al (2020) Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson\u2019s disease. Free Radic Biol Med 152:227\u2013234","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5257_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/mds.27275","volume":"33","author":"C Moreau","year":"2018","unstructured":"Moreau C, Duce JA, Rascol O et al (2018) Iron as a therapeutic target for Parkinson\u2019s disease. Mov Disord 33(4):568\u2013574","journal-title":"Mov Disord"},{"key":"5257_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","volume":"94","author":"B Van Do","year":"2016","unstructured":"Van Do B, Gouel F, Jonneaux A et al (2016) Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC. Neurobiol Dis 94:169\u2013178","journal-title":"Neurobiol Dis"},{"issue":"8","key":"5257_CR15","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1007\/s12035-017-0846-2","volume":"55","author":"E S\u00e1nchez","year":"2018","unstructured":"S\u00e1nchez E, Azcona LJ, Pais\u00e1n-Ruiz C (2018) Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased \u03b2-Synuclein Expression, and Defects in Brain Functions and Pathways. Mol Neurobiol 55(8):6734\u20136754","journal-title":"Mol Neurobiol"},{"issue":"6","key":"5257_CR16","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s12035-018-1118-5","volume":"56","author":"CC Chiu","year":"2019","unstructured":"Chiu CC, Lu CS, Weng YH et al (2019) PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model. Mol Neurobiol 56(6):3835\u20133853","journal-title":"Mol Neurobiol"},{"issue":"44","key":"5257_CR17","doi-asserted-by":"publisher","first-page":"27319","DOI":"10.1073\/pnas.2009201117","volume":"117","author":"O Beharier","year":"2020","unstructured":"Beharier O, Tyurin VA, Goff JP et al (2020) PLA2G6 guards placental trophoblasts against ferroptotic injury. Proc Natl Acad Sci U S A 117(44):27319\u201327328","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5257_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41589-020-00734-x","volume":"17","author":"WY Sun","year":"2021","unstructured":"Sun WY, Tyurin VA, Mikulska-Ruminska K et al (2021) Phospholipase iPLA2\u03b2 averts ferroptosis by eliminating a redox lipid death signal. Nat Chem Biol 17(4):465\u2013476","journal-title":"Nat Chem Biol"},{"key":"5257_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","volume":"12","author":"WS Hambright","year":"2017","unstructured":"Hambright WS, Fonseca RS, Chen L, Na R, Ran Q (2017) Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol 12:8\u201317","journal-title":"Redox Biol"},{"issue":"1","key":"5257_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-018-0236-x","volume":"13","author":"J Guo","year":"2018","unstructured":"Guo J, Cui Y, Liu Q et al (2018) Piperine ameliorates SCA17 neuropathology by reducing ER stress. Mol Neurodegener 13(1):4","journal-title":"Mol Neurodegener"},{"issue":"4","key":"5257_CR21","first-page":"605","volume":"28","author":"G Lin","year":"2018","unstructured":"Lin G, Lee PT, Chen K et al (2018) Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels. Similar to \u03b1-Synuclein Gain Cell Metab 28(4):605-618.e6","journal-title":"Similar to \u03b1-Synuclein Gain Cell Metab"},{"issue":"4","key":"5257_CR22","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","volume":"17","author":"Y Tian","year":"2020","unstructured":"Tian Y, Lu J, Hao X et al (2020) FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson\u2019s Disease. Neurotherapeutics 17(4):1796\u20131812","journal-title":"Neurotherapeutics"},{"issue":"4","key":"5257_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/cns.13548","volume":"27","author":"XF Qu","year":"2021","unstructured":"Qu XF, Liang TY, Wu DG et al (2021) Acyl-CoA synthetase long chain family member 4 plays detrimental role in early brain injury after subarachnoid hemorrhage in rats by inducing ferroptosis. CNS Neurosci Ther 27(4):449\u2013463","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"5257_CR24","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1523\/JNEUROSCI.4354-07.2008","volume":"28","author":"K Shinzawa","year":"2008","unstructured":"Shinzawa K, Sumi H, Ikawa M et al (2008) Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J Neurosci 28(9):2212\u20132220","journal-title":"J Neurosci"},{"issue":"3","key":"5257_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka O, Shah R, Li B et al (2017) On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death. ACS Cent Sci 3(3):232\u2013243","journal-title":"ACS Cent Sci"},{"issue":"4","key":"5257_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12264-020-00620-5","volume":"37","author":"Y Cao","year":"2021","unstructured":"Cao Y, Li Y, He C et al (2021) Selective Ferroptosis Inhibitor Liproxstatin-1 Attenuates Neurological Deficits and Neuroinflammation After Subarachnoid Hemorrhage. Neurosci Bull 37(4):535\u2013549","journal-title":"Neurosci Bull"},{"key":"5257_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto G, Rossetto M, Di Paolo ML et al (2020) Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol 28:101328","journal-title":"Redox Biol"},{"key":"5257_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.redox.2017.08.008","volume":"14","author":"AB Fisher","year":"2018","unstructured":"Fisher AB, Vasquez-Medina JP, Dodia C, Sorokina EM, Tao JQ, Feinstein SI (2018) Peroxiredoxin 6 phospholipid hydroperoxidase activity in the repair of peroxidized cell membranes. Redox Biol 14:41\u201346","journal-title":"Redox Biol"},{"issue":"10","key":"5257_CR29","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41401-019-0233-9","volume":"40","author":"B Lu","year":"2019","unstructured":"Lu B, Chen XB, Hong YC et al (2019) Identification of PRDX6 as a regulator of ferroptosis. Acta Pharmacol Sin 40(10):1334\u20131342","journal-title":"Acta Pharmacol Sin"},{"issue":"21","key":"5257_CR30","doi-asserted-by":"publisher","first-page":"12987","DOI":"10.3390\/ijms232112987","volume":"23","author":"M Di Sanzo","year":"2022","unstructured":"Di Sanzo M, Cozzolino F, Battaglia AM et al (2022) Ferritin Heavy Chain Binds Peroxiredoxin 6 and Inhibits Cell Proliferation and Migration. Int J Mol Sci 23(21):12987","journal-title":"Int J Mol Sci"},{"key":"5257_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.freeradbiomed.2024.04.208","volume":"218","author":"JM Torres-Velarde","year":"2024","unstructured":"Torres-Velarde JM, Allen KN, Salvador-Pascual A et al (2024) Peroxiredoxin 6 suppresses ferroptosis in lung endothelial cells. Free Radic Biol Med 218:82\u201393","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"5257_CR32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41594-024-01329-z","volume":"31","author":"H Fujita","year":"2024","unstructured":"Fujita H, Tanaka YK, Ogata S et al (2024) PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis. Nat Struct Mol Biol 31(8):1277\u20131285","journal-title":"Nat Struct Mol Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05257-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:14:17Z","timestamp":1761570857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05257-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5257"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05257-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve human subjects. The animal experiments were approved by the Ethics Committee for Animal Experiments of Xiangya Hospital of Central South University (201803471).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}